Business Standard

Sunday, January 05, 2025 | 05:05 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Zydus receives final approval for Diltiazem Hydrochloride Extended-Release Capsules

Image

Capital Market

From USFDA

Zydus Cadila has received the final approval from the USFDA to market Diltiazem Hydrochloride Extended-Release Capsules USP in strengths of 120 mg, 180 mg, 240 mg, 300 mg and 360 mg. The drug is used in the treatment of hypertension (high blood pressure), angina (chest pain) and certain heart rhythm disorders. It will produced at the group's formulations manufacturing facility at the Pharma SEZ in Ahmedabad.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 09 2017 | 11:42 AM IST

Explore News